Truist Securities Starts Kymera Therapeutics (KYMR) at Buy
Tweet Send to a Friend
(Updated - June 30, 2023 6:02 AM EDT)
Truist Securities analyst Srikripa Devarakonda initiates coverage on Kymera Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Truist Securities analyst Srikripa Devarakonda initiates coverage on Kymera Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
